Christopher E. Cannon
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 4
-
- Neurotransmitter Receptor Influence on Behavior 2
- Neuroscience and Neuropharmacology Research 2
- Co-authors
- Jason M. Uslaner (7 shared papers)Scott D. Kuduk (3 shared papers)Donnie M. Eddins (4 shared papers)Henry S. Lange (2 shared papers)Joshua D. Vardigan (3 shared papers)Jeffrey A. Vivian (3 shared papers)John J. Renger (2 shared papers)Marion Wittmann (2 shared papers)
- Journals
- Psychopharmacology (4 papers)Neuropharmacology (3 papers)Neurotherapeutics (1 paper)Science Translational Medicine (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesSingapore
In The Last Decade
Christopher E. Cannon
10 papers receiving 400 citations
Peers
Comparison fields: 5 of 38
- Cellular and Molecular Neuroscience 84
- Pharmacology 65
- Psychiatry and Mental health 69
- Cognitive Neuroscience 68
- Molecular Biology 181
Countries citing papers authored by Christopher E. Cannon
This map shows the geographic impact of Christopher E. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Cannon more than expected).
Fields of papers citing papers by Christopher E. Cannon
This network shows the impact of papers produced by Christopher E. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Cannon. The network helps show where Christopher E. Cannon may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Cannon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 80 | |
| 2 | 2012 | 77 | |
| 3 | 2012 | 63 | |
| 4 | 2015 | 60 | |
| 5 | 2014 | 53 | |
| 6 | 2013 | 32 | |
| 7 | 2012 | 30 | |
| 8 | 2021 | 17 | |
| 9 | 2025 | 2 | |
| 10 | 2025 | 1 |
About Christopher E. Cannon
Christopher E. Cannon is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Physiology, Psychiatry and Mental health and Biochemistry, having authored 10 papers that have together received 415 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Schizophrenia research and treatment (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Sleep and Wakefulness Research (1 paper), Nicotinic Acetylcholine Receptors Study (1 paper) and Phosphodiesterase function and regulation (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (84 citations), Pharmacology (65 citations), Psychiatry and Mental health (69 citations), Cognitive Neuroscience (68 citations) and Molecular Biology (181 citations). Christopher E. Cannon has collaborated with scholars based in United States and Singapore. Frequent co-authors include Jason M. Uslaner, Scott D. Kuduk, Donnie M. Eddins, Henry S. Lange, Joshua D. Vardigan, Jeffrey A. Vivian, John J. Renger, Marion Wittmann, William J. Ray and Monika Kandebo. Their work appears in journals such as Psychopharmacology, Neuropharmacology, Neurotherapeutics, Science Translational Medicine and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.